Unlock instant, AI-driven research and patent intelligence for your innovation.

Production methods of luliconazole and hydrochloride thereof

A technology of luliconazole hydrochloride and luliconazole, applied in the field of medicine, can solve the problems of unfavorable large-scale mass production, affecting drug efficacy, low yield and the like, and achieves the effects of easy separation and purification, low cost and high yield

Active Publication Date: 2021-10-22
SHANGHAI VIWIT PHARMA CO LTD
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] However, for luliconazole (E configuration) as a drug, it is not only necessary to strictly control the content of impurities such as unreacted raw materials and by-products to improve its purity, but also to strictly control its enantiomer (Z configuration). ) content to improve its optical purity, because for luliconazole (E configuration), its enantiomer (Z configuration) is also an impurity, which affects its efficacy
[0006] In order to meet the high requirements of luliconazole (E configuration) in terms of purity and optical purity, Chinese patent CN1194582A provides a milligram-level laboratory preparation method, which is to mix 1-cyanomethylimidazole, carbon disulfide, and potassium hydroxide in The dithiolate solution generated by the reaction in DMSO was added dropwise to the DMSO solution of (S)-1-[(2,4-dichlorophenyl)-2-bromoethyl]methanesulfonate, and the reaction was complete with stirring Finally, the reaction mixture was poured into ice water, extracted with ethyl acetate, the organic phase was washed and dried, and the solvent was removed, the residue was purified by silica gel column chromatography, and then recrystallized with a mixed solvent of ethyl acetate-n-hexane, Obtained 350 mg of product with an optical purity of 95% enantiomeric excess, based on (S)-1-[(2,4-dichlorophenyl)-2-bromoethyl] methanesulfonate, the yield was 36%; it can be seen that this method needs to be purified by silica gel column chromatography, which is not conducive to large-scale mass production, and is only applicable to the laboratory level. After the two measures, the optical purity can reach 95%, which is still not ideal, and the yield is not high at the same time
[0007] The Chinese patent application CN105566309A discloses a synthetic method for luliconazole, in which the reaction solution of cyanomethylimidazole, carbon disulfide and sodium hydroxide in DMSO is added dropwise to compound 4((S)-2,2',4'-tri Chlorobenzene methanesulfonate) in DMSO solution, reacted overnight at room temperature, then added to ice water, added ethyl acetate, stirred and separated, the water layer was extracted with ethyl acetate, combined organic phase, washed with saturated sodium chloride solution , concentrate, add sherwood oil, stir, separate out solid, filter, dry, recrystallize with ethyl acetate, obtain orange-yellow solid 142g, yield 40%; Although this method is improved to the output level of gram, yield also improves slightly , but from the orange-yellow appearance of its products, it is not advisable to sacrifice the quality of the product (eg, purity, optical purity, etc.)

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Production methods of luliconazole and hydrochloride thereof
  • Production methods of luliconazole and hydrochloride thereof
  • Production methods of luliconazole and hydrochloride thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0119] 1. Production of crude luliconazole

[0120] The production method of luliconazole crude product, comprises the following steps:

[0121] ①,

[0122]

[0123] Under the protection of an inert gas (for example, nitrogen, etc.), add 235.2kg dimethyl sulfoxide, 30kg 1-cyanomethylimidazole (compound IV, about 280mol) and 21.7kg carbon disulfide (about 285mol) into the reactor, and start Stirring, the stirring rate is 100r / min~550r / min (the present embodiment adopts 250r / min, and the stirring rate has little influence on the reaction), and the temperature in the control kettle is 5°C~20°C (considering energy saving and consumption reduction, this implementation For example, under the conditions of preferably 10°C to 20°C), add 30.4kg of potassium hydroxide (about 542mol) to the above solution at a rate of 6.0kg / h to 12.0kg / h. After the addition, continue to stir and react for 4h ~12h (this embodiment is 4h), obtain the reaction solution containing compound III;

[0124...

Embodiment 2 and 3

[0143] The same content as in Example 1 is not repeated, and the difference is that in step 1., the mol ratio of 1-cyanomethylimidazole and potassium hydroxide is 1:1.8, 1:2.1 respectively, and the addition of potassium hydroxide is changed , the crude luliconazole was obtained, the purity was 69.0%, 68.5%, and the e.e. values ​​were 99.80%, 96.4%, respectively.

Embodiment 4 and 5

[0145] The same content as in Example 1 will not be repeated. The difference is that in step 1., the molar ratio of 1-cyanomethylimidazole to carbon disulfide is 1:0.8 and 1:1.2 respectively, and the amount of carbon disulfide added is changed to obtain luliconazole The purity of the crude product is NA (not detected), 66.0%, and the e.e. values ​​are 54.8%, 99.85%, respectively.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
purityaaaaaaaaaa
Login to View More

Abstract

The invention discloses production methods of luliconazole and hydrochloride thereof. The production method of the luliconazole hydrochloride comprises the following step of: i, with or without inert gas protection, reacting a luliconazole product with hydrogen chloride in a mixed solvent of an ether solvent and an ester solvent to obtain the luliconazole hydrochloride. The production method of the luliconazole comprises the following step of: a, with or without inert gas protection, reacting the luliconazole hydrochloride with an alkaline substance in a mixed solvent of water and an ester solvent to obtain luliconazole. According to the methods disclosed by the invention, the luliconazole hydrochloride and the alkaline substance react to produce luliconazole, the target product is convenient to separate and purify, a luliconazole product with high purity and high e.e. value can be conveniently obtained, and a brand new process route is provided for the production of luliconazole.

Description

technical field [0001] The invention belongs to the field of medicine, and in particular relates to a production method of luliconazole and its hydrochloride. Background technique [0002] Luliconazole, CAS number: 187164-19-8, chemical name: (R,E)-2-(4-(2,4-dichlorophenyl)-1,3-dithiolane-2-ylidene )-2-(1H-imidazol-1-yl)acetonitrile, English name: (R,E)-2-(4-(2,4-Dichlorophenyl)-1,3-dithiolan-2-ylidene)-2- (1H-imidazol-1-yl)acetonitrile, its structural formula is as follows: [0003] [0004] Luliconazole is an imidazole antifungal drug, which mainly inhibits the activity of lanosterol demethylase and reduces the level of ergosterol to interfere with the synthesis of fungal cell walls and the growth of fungi, except for the treatment of tinea pedis and jock itch In addition to tinea corporis, it is also developed for onychomycosis (onychomycosis) treatment, etc., and its products have been listed and sold in countries and regions such as Japan, India, China and the Unit...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D409/06A61P31/10
CPCC07D409/06A61P31/10
Inventor 魏彦君贾林徐青景刘希望胡青燕邢艳平
Owner SHANGHAI VIWIT PHARMA CO LTD